Beta-blocker use is associated with lower stroke and death after carotid artery stenting Tammam Obeid, MBBS, Isibor Arhuidese, MBBS, MPH, Alicia Gaidry, MC, USNR, Umair Qazi, MD, MPH, Christopher Abularrage, MD, Philip Goodney, MD, Jack Cronenwett, MD, Mahmoud Malas, MD, MHS Journal of Vascular Surgery Volume 63, Issue 2, Pages 363-369 (February 2016) DOI: 10.1016/j.jvs.2015.08.108 Copyright © 2016 Society for Vascular Surgery Terms and Conditions
Fig Multivariate logistic regression of 30-day stroke or death after carotid artery stenting (CAS). ∗P value < .05. CAD, Coronary artery disease; CEA, carotid endarterectomy; CI, confidence interval; HTN, hypertension; ICA, internal carotid artery. aAdjusted for age, sex, comorbidities (diabetes, hypertension, coronary artery disease), preoperative medication (aspirin, statin, P2Y12 antagonist, beta blockers), smoking, symptomatic, prior CEA, postprocedural hypotension, postprocedural hypertension, embolic protection use, stenosis degree, approach, and volume of contrast material used. Journal of Vascular Surgery 2016 63, 363-369DOI: (10.1016/j.jvs.2015.08.108) Copyright © 2016 Society for Vascular Surgery Terms and Conditions